BackNKGen Biotech- Warrants (01/09/2028) Overview

NKGen Biotech- Warrants (01/09/2028) Total Current Liabilities

Track NKGen Biotech- Warrants (01/09/2028)'s total current liabilities ($44M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$43.89M
17.09% YoYΔ $6.41M vs prior year quarter

Peer trimmed avg / median

Loading

NKGen Biotech- Warrants (01/09/2028) Total Current Liabilities History

Loading

NKGen Biotech- Warrants (01/09/2028) vs. peers: Total Current Liabilities Comparison

Loading

NKGen Biotech- Warrants (01/09/2028) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NKGen Biotech- Warrants (01/09/2028) (NKGNW) FAQ

NKGen Biotech- Warrants (01/09/2028) posts a total current liabilities of $44M as of March 2025. That compares with $37M in the prior-year period — up 17.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, NKGen Biotech- Warrants (01/09/2028)'s total current liabilities was $37M. The latest reading is $44M — a 17.1% year-over-year increase (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

Total Current Liabilities is one piece of NKGen Biotech- Warrants (01/09/2028)'s financial statement story. At $44M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NKGNW's total current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; NKGen Biotech- Warrants (01/09/2028)'s other metric pages and overview cover the third.